Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSMB11 | A5LHX3 | 1/20 | 0.42 |
| ▸ | PSMA7 | O14818 | 1/20 | 0.42 |
| ▸ | PSMB1 | P20618 | 1/20 | 0.42 |
| ▸ | PSMA1 | P25786 | 1/20 | 0.42 |
| ▸ | PSMA2 | P25787 | 1/20 | 0.42 |
| ▸ | PSMA3 | P25788 | 1/20 | 0.42 |
| ▸ | PSMA4 | P25789 | 1/20 | 0.42 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.42 |
| ▸ | PSMB9 | P28065 | 1/20 | 0.42 |
| ▸ | PSMA5 | P28066 | 1/20 | 0.42 |
| ▸ | PSMB4 | P28070 | 1/20 | 0.42 |
| ▸ | PSMB6 | P28072 | 1/20 | 0.42 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.42 |
| ▸ | PSMB10 | P40306 | 1/20 | 0.42 |
| ▸ | PSMB3 | P49720 | 1/20 | 0.42 |
| ▸ | PSMB2 | P49721 | 1/20 | 0.42 |
| ▸ | PSMA6 | P60900 | 1/20 | 0.42 |
| ▸ | PSMA8 | Q8TAA3 | 1/20 | 0.42 |
| ▸ | PSMB7 | Q99436 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9776250 | 0.91 | CNR1 (0.46) | PSMB11PSMA7PSMB1PSMA1PSMA2 | |
| SCHEMBL10016301 | 0.88 | CNR1 (0.55) | PSMB11PSMA7PSMB1PSMA1PSMA2 | |
| SCHEMBL4884498 | 0.88 | ALDH1A1 (0.44) | PSMB11PSMA7PSMB1PSMA1PSMA2 | |
| SCHEMBL4884486 | 0.88 | ALDH1A1 (0.44) | PSMB11PSMA7PSMB1PSMA1PSMA2 | |
| SCHEMBL6370037 | 0.86 | TAS1R3 (0.55) | TAS1R3TAS1R1CNR1CNR2FAAH | |
| SCHEMBL4408974 | 0.86 | PSMB11 (0.51) | PSMB11PSMA7PSMB1PSMA1PSMA2 | |
| SCHEMBL4882014 | 0.86 | PSMB11 (0.51) | PSMB11PSMA7PSMB1PSMA1PSMA2 | |
| SCHEMBL3951480 | 0.83 | CNR1 (0.47) | MAPTTAS1R3TAS1R1CNR1CNR2 | |
| SCHEMBL4888803 | 0.83 | CNR1 (0.47) | MAPTTAS1R3TAS1R1CNR1CNR2 | |
| SCHEMBL302274 | 0.83 | CNR1 (0.47) | MAPTTAS1R3TAS1R1CNR1CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240016706-A1 | MATERIALS FOR OBTURATION | SONENDO, INC. | 2024-01-18 | — | — | US | claimed |
| WO-2022099258-A1 | MATERIALS FOR OBTURATION | SONENDO, INC. (US) | 2022-05-12 | — | — | WO | claimed |
| EP-2226061-B2 | Infiltrant for dental application | ERNST MÜHLBAUER GMBH & CO KG (DE) | 2017-01-25 | — | — | EP | claimed |
| US-9211236-B2 | Infiltrant for dental application | MUHLBAUER GMBH & CO. KG (DE) | 2015-12-15 | — | — | US | claimed |
| US-20130116384-A1 | INFILTRANT FOR DENTAL APPLICATION | ERNST MUHLBAUER GMBH & CO. KG (DE) | 2013-05-09 | — | — | US | claimed |
| EP-2226061-B1 | Infiltrant for dental application | MUEHLBAUER ERNST GMBH & CO KG (DE) | 2012-12-26 | — | — | EP | claimed |
| US-20100240853-A1 | INFILTRANT FOR DENTAL APPLICATION | ERNST MÜHLBAUER GMBH & CO. KG (DE) | 2010-09-23 | — | — | US | claimed |
| EP-2226061-A1 | Infiltrant for dental application | Ernst Mühlbauer GmbH & Co.KG (DE) | 2010-09-08 | — | — | EP | claimed |
| EP-4584243-A1 | CROSSLINKERS | Hemoteq AG (DE) | 2025-07-16 | — | — | EP | disclosed |
| EP-4584245-A1 | COPOLYMERS OF N-VINYLPYRROLIDONE WITH FUNCTIONALIZED MALEIC ACID MOIETIES | Hemoteq AG (DE) | 2025-07-16 | — | — | EP | disclosed |
| EP-4584244-A1 | COPOLYMERS OF N-VINYLPYRROLIDONE WITH FUNCTIONALIZED MALEIC ACID MOIETIES | Hemoteq AG (DE) | 2025-07-16 | — | — | EP | disclosed |
| WO-2025056815-A1 | COPOLYMERS OF N-VINYLPYRROLIDONE WITH FUNCTIONALIZED MALEIC ACID MOIETIES | HEMOTEQ AG (DE) | 2025-03-20 | — | — | WO | disclosed |
| WO-2025056814-A1 | CROSSLINKERS | HEMOTEQ AG (DE) | 2025-03-20 | — | — | WO | disclosed |
| WO-2025056813-A1 | COPOLYMERS OF N-VINYLPYRROLIDONE WITH FUNCTIONALIZED MALEIC ACID MOIETIES | HEMOTEQ AG (DE) | 2025-03-20 | — | — | WO | disclosed |
| EP-1222910-B1 | Polyfunctional amide containing dental material | IVOCLAR VIVADENT AG (LI) | 2010-05-19 | — | — | EP | disclosed |
| US-20100041790-A1 | SELF-ETCHING DENTAL MATERIALS BASED ON (METH)ACRYLAMIDE PHOSPHATES | IVOCLAR VIVADENT AG (LI) | 2010-02-18 | — | — | US | disclosed |
| US-6953832-B2 | Dental materials based on polyfunctional amides | IVOCLAR VIVADENT AG (LI) | 2005-10-11 | — | — | US | disclosed |
| US-6900251-B2 | Dental materials based on acrylic-ester phosphonic acids | IVOCLAR VIVADENT AG (LI) | 2005-05-31 | — | — | US | disclosed |
| US-20020143138-A1 | For use as dental adhesive, coating material, filling material or dental cement | IVOCLAR VIVADENT AG (LI) | 2002-10-03 | — | — | US | disclosed |
| EP-1222910-A2 | Polyfunctional amide containing dental material | Ivoclar Vivadent AG (LI) | 2002-07-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100041790-A1 | SELF-ETCHING DENTAL MATERIALS BASED ON (METH)ACRYLAMIDE PHOSPHATES | MSR1, C1R, HRH3 | PSMB11 1177/4885PSMA7 2386/4885PSMB1 1103/4885 |
| US-20240016706-A1 | MATERIALS FOR OBTURATION | ACR, GMPS, AAAS | PSMB11 2146/4885PSMA7 1693/4885PSMB1 2052/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.